Leu-Leu-ome hydrochloride

CAS No. 6491-83-4

Leu-Leu-ome hydrochloride( —— )

Catalog No. M20979 CAS No. 6491-83-4

Leu-Leu-ome hydrochloride is a lysosomal condensation product that cytotoxic towards natural killer cells and CD4+ and CD8+ T lymphocytes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
100MG 38 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Leu-Leu-ome hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Leu-Leu-ome hydrochloride is a lysosomal condensation product that cytotoxic towards natural killer cells and CD4+ and CD8+ T lymphocytes.
  • Description
    Leu-Leu-ome hydrochloride is a lysosomal condensation product that cytotoxic towards natural killer cells and CD4+ and CD8+ T lymphocytes.
  • In Vitro
    L-Leucyl-L-Leucine methyl ester (1 mM; 0.5-2 h) enhances LRRK2-mediated Rab10 and Rab12 phosphorylation in MEFs and A549 cells.L-Leucyl-L-Leucine methyl ester (10-250 μM; 15 min) is converted to a CCI3COOH-insoluble product by CD4- lymphocytes.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6491-83-4
  • Formula Weight
    294.81
  • Molecular Formula
    C13H27ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (847.98 mM)
  • SMILES
    COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Giusti P Skaper S D Marinelli C et al. Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype[J]. CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets 2013 12(5):-.
molnova catalog
related products
  • CPI-1189

    REN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.

  • FUBP1-IN-1

    FUBP1 - in-1, with an IC50 value of 11.0 M, is an effective FUSE binding protein 1 (FUBP1) inhibitor that can interfere with the binding of FUBP1 to its SINGLE-strand target DNA FUSE sequence.

  • WL 47 - dimer

    High affinity caveolin-1 (CAV1) ligand (Kd = 23 nM); disrupts caveolin-1 oligomers. Exhibits selectivity for CAV1 over BSA, casein and HEWL.